Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Med Oral Patol Oral Cir Bucal ; 18(2): e226-32, 2013 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-23385503

RESUMEN

OBJECTIVE: The aim of this study was to evaluate the response of treatment of central giant cell lesion to intralesional corticosteroid injections. STUDY DESIGN: Review of articles indexed in PubMed on the topic between the years 1988 and 2011, and development of a descriptive meta-analysis of the results. RESULTS: Sample of 41 patients primarily treated with intralesional corticosteroid injections was obtained, with a male female ratio of 1:0.95, being 23 aggressive and 18 non-aggressive central giant cell lesions. Triamcinolone acetonide and triamcinolone hexacetonide were the drugs used, and 78.0% cases were considered as good result, 14.6% were considered as moderate response and 7.3% were considered as negative result to treatment. Considering the aggressiveness, 88.9% of non-aggressive lesions presented a good response to treatment, in aggressive central giant cell lesions, 69.6% presented a good response to intralesional corticosteroid injections. CONCLUSION: In view of the results analyzed, intralesional corticosteroid injections could be considered as first treatment option for central giant cell lesion.


Asunto(s)
Corticoesteroides/administración & dosificación , Tumores de Células Gigantes/tratamiento farmacológico , Neoplasias Maxilomandibulares/tratamiento farmacológico , Femenino , Humanos , Inyecciones Intralesiones , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA